Assembly Biosciences ASMB
NASDAQ ASMB
$22.54 -0.44 (-1.91%)
At close: Oct 2, 2026 · 4:00 PM EDT

Assembly Biosciences (ASMB) Return on Sales [ROS] (2017 - 2026)

Updated

Assembly Biosciences' Return on Sales [ROS] came in at -47.44% for Q2 2026, up 67.80 percentage points from -115.24% a year earlier and up 91.00 percentage points from the prior quarter.

Analysis

Assembly Biosciences (ASMB) Return on Sales [ROS] (2017 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Assembly Biosciences reported Return on Sales [ROS] of -11.75%, up 119.15 percentage points year-over-year; for FY2025, it came in at -16.76%, up 142.50 percentage points from FY2024.

  • Return on Sales [ROS] carries a five-year change of +65.13 percentage points (FY2020 to FY2025).
  • Going back by year, Return on Sales [ROS] was -159.26% in FY2024 (+743.24 pp), -902.50% in FY2023 and -2121.65% in FY2021 (-2039.76 pp).
  • The five-year range for quarterly Return on Sales [ROS] is -2121.65% (Q4 2021) to 46.62% (Q4 2025).
  • Year-over-year, Return on Sales [ROS] increased in six of the last seven quarters, with an average year-over-year change of +60.52 percentage points.
  • The fastest year-over-year change in Return on Sales [ROS] over five years came in Q4 2021 (a gain of 1701.11 percentage points), and the weakest in Q3 2021 (a drop of 290.19 percentage points).
  • Business Quant data shows ASMB's Return on Sales [ROS] at -138.44% (Q1 2026), 46.62% (Q4 2025) and -100.87% (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 28.21%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 37.86%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -3.52%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 32.97%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 20.57%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 34.95%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -133.21%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 28.37%
10 Assembly Biosciences 447.43 Mn -580.20 Mn - -47.44%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -47.44%
Mar 31, 2026 -138.44%
Dec 31, 2025 46.62%
Sep 30, 2025 -100.87%
Jun 30, 2025 -115.24%
Mar 31, 2025 -105.54%
Dec 31, 2024 -156.75%
Sep 30, 2024 -160.06%
Jun 30, 2024 -143.01%
Mar 31, 2024 -185.46%
Dec 31, 2023 -175.22%
Jun 30, 2023 -1,333.96%
Mar 31, 2023 -1,447.25%
Dec 31, 2021 -2,121.65%
Sep 30, 2021 -301.81%
Jun 30, 2021 -265.33%
Mar 31, 2021 -85.76%
Dec 31, 2020 -3,822.76%
Sep 30, 2020 -11.61%
Jun 30, 2020 16.71%
API Access

Assembly Biosciences Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=ASMB&period=max&api_key=YOUR_API_KEY